Safety, Tolerability and Blood Sampling of GSK3923868 Administered via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry

Trial Identifier:	218320
Sponsor:	GlaxoSmithKline
Start Date:	September 2024
Primary Completion Date:	November 2024
Study Completion Date:	November 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Middlesex, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.